Tibet Cheezheng Tibetan Medicine Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000FM9
CNY
24.85
-0.01 (-0.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,298.50
2,010.31
2,015.14
1,741.72
1,459.38
1,380.36
1,189.63
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,298.50
2,010.31
2,015.14
1,741.72
1,459.38
1,380.36
1,189.63
Raw Material Cost
474.47
382.42
382.00
309.10
242.66
202.41
159.61
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
214.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
60.36
66.79
61.09
56.12
23.03
4.97
9.61
Selling and Distribution Expenses
1,230.22
1,111.92
1,057.68
952.54
807.44
806.85
690.92
Other Expenses
0.00
-1.63
-1.36
0.75
3.40
4.77
-18.99
Total Expenditure (Excl Depreciation)
1,765.09
1,544.88
1,487.14
1,325.22
1,107.10
1,061.93
884.53
Operating Profit (PBDIT) excl Other Income
533.4000000000001
465.4
528
416.5
352.29999999999995
318.4
305.1
Other Income
72.91
205.96
113.09
129.89
112.62
85.63
50.18
Operating Profit (PBDIT)
748.37
768.01
724.54
612.65
508.75
440.05
379.85
Interest
60.36
66.79
61.09
56.12
23.03
4.97
9.61
Exceptional Items
105.14
37.07
-3.43
4.57
0.97
2.27
-0.38
Gross Profit (PBDT)
1,824.03
1,627.90
1,633.14
1,432.62
1,216.72
1,177.94
1,030.02
Depreciation
140.37
95.77
85.91
66.54
43.84
36.09
24.58
Profit Before Tax
652.78
642.52
574.11
494.55
442.85
401.26
345.28
Tax
64.87
65.24
49.56
77.09
40.78
36.87
32.89
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
582.28
581.20
472.54
715.88
403.96
364.25
318.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
582.28
581.20
472.54
715.88
403.96
364.25
318.77
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.91
-2.02
-2.90
-5.05
0.22
0.14
-1.33
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
581.37
579.18
469.64
710.83
404.18
364.39
317.44
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,064.38
3,720.33
3,335.91
3,169.03
2,619.02
2,245.54
2,029.29
Earnings per share (EPS)
1.1
1.1
0.89
1.35
0.76
0.69
0.6
Diluted Earnings per share
1.1
1.1
0.89
1.35
0.76
0.69
0.6
Operating Profit Margin (Excl OI)
23.28%
23.19%
26.08%
23.9%
24.14%
23.06%
25.65%
Gross Profit Margin
34.51%
36.73%
32.75%
32.21%
33.35%
31.68%
31.09%
PAT Margin
25.33%
28.91%
23.45%
41.1%
27.68%
26.39%
26.8%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 14.34% vs -0.24% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 0.38% vs 23.34% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 20.17% vs -8.08% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -9.58% vs 9.33% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Tibet Cheezheng Tibetan Medicine Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,298.50
0
2,298.50
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,298.50
0
2,298.50
Raw Material Cost
474.47
0
474.47
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
60.36
0
60.36
Selling and Distribution Expenses
1,230.22
0
1,230.22
Other Expenses
0.00
0.00
0.00
Total Expenditure (Excl Depreciation)
1,765.09
0
1,765.09
Operating Profit (PBDIT) excl Other Income
533.41
0.00
533.41
Other Income
72.91
0
72.91
Operating Profit (PBDIT)
748.37
0
748.37
Interest
60.36
0
60.36
Exceptional Items
105.14
0
105.14
Gross Profit (PBDT)
1,824.03
0
1,824.03
Depreciation
140.37
0
140.37
Profit Before Tax
652.78
0
652.78
Tax
64.87
0
64.87
Provisions and contingencies
0
0
0.00
Profit After Tax
582.28
0
582.28
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
582.28
0
582.28
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.91
0
-0.91
Other related items
0.00
0.00
0.00
Consolidated Net Profit
581.37
0
581.37
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,064.38
0
4,064.38
Earnings per share (EPS)
1.10
0
1.10
Diluted Earnings per share
1.10
0
1.10
Operating Profit Margin (Excl OI)
23.28%
0%
0.00
23.28%
Gross Profit Margin
34.51%
0%
0.00
34.51%
PAT Margin
25.33%
0%
0.00
25.33%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 229.85 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 14.34% vs -0.24% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 58.14 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.38% vs 23.34% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 67.55 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 20.17% vs -8.08% in Dec 2023

Annual - Interest
Interest 6.04 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -9.58% vs 9.33% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.28%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023